Previous studies showed that enhanced glucose intake in transgenic mice expressing human GLUT4 under its own promoter improved insulin sensitivity, but reduced lipid oxidation in the skeletal muscle and did not alleviate obesity under HFD.11 The gene discussed is SLC2A4; the disease is obesity due to melanocortin 4 receptor deficiency.